AbbVie Inc. (ABBV) Financials
Annual revenue, profitability and per-share results for AbbVie Inc., as reported in SEC filings.
Revenue • FY2025
$61.16B
▲ 8.6%YoY
Net income • FY2025
$4.23B
▼ 1.2%YoY
Gross margin • FY2025
70.2%
Diluted EPS • FY2025
$2.36
▼ 1.3%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $61.16B | $4.23B | $42.96B | $2.36 | $17.82B | 24.6% | +8.6% |
| FY2024 | $56.33B | $4.28B | $39.43B | $2.39 | $17.83B | 16.2% | +3.7% |
| FY2023 | $54.32B | $4.86B | $33.9B | $2.72 | $22.06B | 23.5% | -6.4% |
| FY2022 | $58.05B | $11.84B | $40.64B | $6.63 | $24.25B | 31.2% | +3.3% |
Figures as reported in AbbVie Inc.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Financials for companies related to ABBV
Never miss a ABBV filing.
Get an email when ABBV files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.